Searched for
BDR PHARMACEUTICALS
BDR Pharmaceutical launches generic drug for treating prostate cancer in IndiaBDR Group Director Business Development Raheel Shah said that the launch of APATIDE is "testimony towards our commitment in providing acces...03 Jan, 2023, 03.33 PM IST- Generic drug companies in no hurry to launch new Covid productsBDR Pharmaceuticals, a Mumbai-based active pharmaceutical ingredient (API) manufacturing company, has developed the API of antiviral pill P...13 Jul, 2022, 12.34 AM IST
- BDR looking to buy majority stake in drug plant in BelarusBDR will be investing $13 million in the Belarus facility. In addition, it is also investing in setting up a formulation manufacturing unit...03 Mar, 2022, 12.32 AM IST
- Multiples Alternate buys into BDR Pharma, invests Rs 750 crET was the first to report in July last year that global and domestic PE funds were in initial discussions to purchase a minority stake in ...24 Jan, 2022, 08.51 AM IST
- Mankind, BDR Pharma join hands to launch anti COVID-19 pill MolulifeMankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti-COVID-19 pill Molulife (Molnupiravir) in ...29 Dec, 2021, 03.02 PM IST
- Global private equity funds in talks to purchase minority stake in BDR PharmaceuticalsFunds like the Carlyle Group, Warburg Pincus and TA Associates are engaged in initial discussions, the people added. Investment bank O3 Cap...23 Jul, 2021, 08.15 AM IST
- Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drugUnder the alliance, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary li...24 Jun, 2021, 04.23 PM IST
- Covid-19: Shortage of black fungus drug loomingOn May 22, there were 8,848 cases across India according to the central government. By May 26, the total number of cases went up to 11,717,...30 May, 2021, 11.35 AM IST
- BDR Pharma launches generic cancer drug in IndiaBDR Pharmaceuticals on Wednesday said it has launched the generic version of Lenvatinib drug for the treatment of various types of cancers ...21 Oct, 2020, 02.28 PM IST
- BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per pack in IndiaThe company had earlier received approval from the Drugs Controller General of India (DCGI) to manufacture 40 mg enzalutamide in 2017 to tr...21 Sep, 2020, 03.45 PM IST
- BDR Pharma to launch 400mg Favipiravir tablets for treating coronavirus patients in IndiaThe company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild ...04 Sep, 2020, 05.38 PM IST
- BDR Pharmaceuticals launches Favipiravir under brand name 'BDFAVI' at Rs 63 per tablet in IndiaBDR pharma has received an approval from the DCGI to manufacture Favipiravir to treat mild to moderate patients with COVID-19 symptoms. The...05 Aug, 2020, 03.51 PM IST
- BDR in pact to make Gilead drug for CiplaIn late May, BDR had sought the approval of India’s drug regulator to make and sell remdesivir in India without entering into an arrangemen...01 Jun, 2020, 07.09 AM IST
- BDR Pharmaceuticals move on Remdesivir clone irks GileadThe Indian company had submitted its application for manufacturing the Covid-19 drug to the Drug Controller General of India (DCGI) last we...28 May, 2020, 08.59 AM IST
- Delhi HC Upholds BMS' Patent for Cancer Drug DasatinibThe Delhi High Court has upheld the patent of US-based BMS for Dasatinib, dashing the hopes of a local company to sell a generic version of...07 Jul, 2015, 10.50 AM IST
- Patent office rejects BDR Pharma’s compulsory licensing applicationThe Patent Office rejected BDR’s application on the grounds that the company did not make enough efforts to obtain a voluntary licence for ...31 Oct, 2013, 05.49 AM IST
- BDR Pharmaceutical's plea for compulsory licence on cancer drug rejectedThe Indian Patent Office has rejected Mumbai-based BDR Pharmaceutical’s application for compulsory licence on cancer drug Dasatinib.12 Sep, 2013, 04.55 AM IST
Load More
